Showing 1 - 10 of 209
We consider a manufacturing system with product recovery. The system manufactures a new product as well as remanufactures the product from old, returned items. The items remanufactured with the returned products are as good as new and satisfy the same demand as the new item. The demand rate for...
Persistent link: https://www.econbiz.de/10010738163
We consider a deterministic model of the manufacturing system with product recovery. Two types of policies for the problem had been proposed in literature, namely the (1,R) policy, in which one manufacturing setup is followed by R remanufacturing setups and the (P,1) policy, which has P...
Persistent link: https://www.econbiz.de/10009146250
Persistent link: https://www.econbiz.de/10009162712
We test the lower bound for a static remanufacturing system with returns proposed by Feng and Viswanathan (2014 …. In contrast to Feng and Viswanathan (2014), we conclude that management should be cautious to use too simple policy …
Persistent link: https://www.econbiz.de/10011077619
An effective planning of lot sizes is a key strategy to efficiently manage a combined manufacturing/remanufacturing system in the presence of substantial setup costs. Due to its complex interdependencies, optimal policies and solutions have not been identified so far, but several heuristic...
Persistent link: https://www.econbiz.de/10010738091
Persistent link: https://www.econbiz.de/10009971744
Persistent link: https://www.econbiz.de/10007737579
Medicare had tried to incorporate outpatient prescription drugs into their benefits regime for many years. Medicare Prescription Drug, Improvement, and Modernization Act of 2003 is the most recent success after the repealed Medicare Catastrophic Coverage Act of 1988. There have been a lot of...
Persistent link: https://www.econbiz.de/10009438889
Persistent link: https://www.econbiz.de/10005414234
Background: The National Institute for Health and Care Excellence (NICE) emphasises that cost-effectiveness is not the only consideration in health technology appraisal and is increasingly explicit about other factors considered relevant. Observing NICE decisions and the evidence considered in...
Persistent link: https://www.econbiz.de/10011133797